Prestige Consumer Healthcare to Release Fiscal 2025 Fourth Quarter and Year-End Earnings Results
Prestige Consumer Healthcare has scheduled its fiscal 2025 fourth quarter and year-end earnings announcement for Thursday, May 8, 2025, before market opening. The company will follow this with a conference call at 8:30 a.m. ET on the same day.
Stakeholders can participate in two ways:
- Through a live Internet webcast accessible via the Investor Relations page at prestigeconsumerhealthcare.com
- Via phone conference by registering online to receive dial-in details and a unique pin
For those joining by phone, it is recommended to connect 10 minutes before the event starts. A replay of the conference call will be available for approximately one week after the event and can be accessed through the company's Investor Relations webpage.
Prestige Consumer Healthcare ha programmato l'annuncio dei risultati del quarto trimestre e dell'intero anno fiscale 2025 per giovedì 8 maggio 2025, prima dell'apertura del mercato. La società terrà una conference call alle 8:30 ET dello stesso giorno.
Gli stakeholder potranno partecipare in due modi:
- Attraverso una diretta web accessibile dalla pagina Investor Relations su prestigeconsumerhealthcare.com
- Tramite conferenza telefonica, registrandosi online per ricevere i dettagli di accesso e un PIN univoco
Per chi parteciperà telefonicamente, è consigliato collegarsi 10 minuti prima dell'inizio dell'evento. La registrazione della conference call sarà disponibile per circa una settimana dopo l'evento e potrà essere consultata nella pagina Investor Relations della società.
Prestige Consumer Healthcare ha programado el anuncio de sus resultados del cuarto trimestre y del año fiscal 2025 para el jueves 8 de mayo de 2025, antes de la apertura del mercado. La compañía realizará una conferencia telefónica a las 8:30 a.m. ET el mismo día.
Los interesados pueden participar de dos maneras:
- A través de una transmisión en vivo por Internet accesible desde la página de Relaciones con Inversionistas en prestigeconsumerhealthcare.com
- Por conferencia telefónica, registrándose en línea para recibir los detalles de acceso y un PIN único
Para quienes se unan por teléfono, se recomienda conectarse 10 minutos antes del inicio. La grabación de la conferencia estará disponible aproximadamente una semana después del evento y podrá accederse desde la página de Relaciones con Inversionistas de la compañía.
Prestige Consumer Healthcare는 2025회계연도 4분기 및 연말 실적 발표를 2025년 5월 8일 목요일, 장 개장 전으로 예정했습니다. 같은 날 오전 8시 30분(동부시간)에 컨퍼런스 콜이 진행됩니다.
이해관계자들은 두 가지 방법으로 참여할 수 있습니다:
- prestigeconsumerhealthcare.com의 투자자 관계 페이지를 통해 실시간 인터넷 웹캐스트 시청
- 온라인 등록을 통해 전화 회의 접속 정보와 고유 PIN을 받아 전화 회의 참여
전화로 참여하는 경우, 행사 시작 10분 전에 접속하는 것이 권장됩니다. 컨퍼런스 콜 녹음은 행사 후 약 일주일간 투자자 관계 웹페이지에서 다시 들을 수 있습니다.
Prestige Consumer Healthcare a programmé l'annonce de ses résultats du quatrième trimestre et de l'exercice 2025 pour le jeudi 8 mai 2025, avant l'ouverture des marchés. Une conférence téléphonique aura lieu le même jour à 8h30 ET.
Les parties prenantes peuvent participer de deux façons :
- Via une diffusion en direct sur Internet accessible depuis la page Relations Investisseurs sur prestigeconsumerhealthcare.com
- Par conférence téléphonique en s'inscrivant en ligne pour recevoir les informations d'accès et un code PIN unique
Il est recommandé aux participants par téléphone de se connecter 10 minutes avant le début de l'événement. La rediffusion de la conférence téléphonique sera disponible pendant environ une semaine après l'événement, accessible via la page Relations Investisseurs de la société.
Prestige Consumer Healthcare hat die Bekanntgabe der Ergebnisse für das vierte Quartal und das Gesamtjahr 2025 für Donnerstag, den 8. Mai 2025, vor Börsenbeginn geplant. Das Unternehmen wird am selben Tag um 8:30 Uhr ET eine Telefonkonferenz abhalten.
Interessierte können auf zwei Arten teilnehmen:
- Über einen Live-Webcast, der auf der Investor-Relations-Seite unter prestigeconsumerhealthcare.com zugänglich ist
- Per Telefonkonferenz, indem man sich online registriert, um Einwahldaten und eine persönliche PIN zu erhalten
Telefonteilnehmer sollten sich empfehlen 10 Minuten vor Beginn einwählen. Eine Aufzeichnung der Telefonkonferenz wird etwa eine Woche lang nach der Veranstaltung auf der Investor-Relations-Webseite des Unternehmens verfügbar sein.
- Timely financial reporting with Q4 and year-end earnings scheduled for May 8, 2025
- Company maintains transparent investor communication through live webcast and conference call
- None.
TARRYTOWN, N.Y., April 10, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2025 fourth quarter and year-end earnings release on Thursday, May 8, 2025 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.
To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com. To participate in the conference call via phone, participants may register for the call here to receive dial-in details and a unique pin. While not required, it is recommended to join 10 minutes prior to the event start.
A conference call replay will be available for approximately one week following completion of the live call and can be accessed on the Company’s Investor Relations page.
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse portfolio of brands include Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® and TheraTears® eye care products, DenTek® specialty oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® and Luden's® sore throat treatments and drops, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Boudreaux’s Butt Paste® diaper rash ointments, Nix® lice treatment, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.
Investor Relations Contact
Phil Terpolilli, CFA, 914-524-6819
irinquiries@prestigebrands.com
FAQ
When will Prestige Consumer Healthcare (PBH) release Q4 2025 earnings?
How can investors join PBH's Q4 2025 earnings call?
What time is Prestige Consumer Healthcare's earnings call on May 8, 2025?
Where can I find the replay of PBH's Q4 2025 earnings call?
What is the registration process for PBH's Q4 2025 earnings call?
